Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes

Roberto Piva(New York University), Giorgio Inghirami(New York University)

Journal of Clinical Investigation

November 17, 2006

10.1172/jci29401

Cited by 164

Related Papers

NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors

|Blood|2003|247

Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas

|Blood|2005|128

15-Deoxy-Δ12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-κB activity and down-regulation of antiapoptotic proteins

|Blood|2004|94

STAT3-mediated activation of microRNA cluster 17 92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma

|Haematologica|2013|53

The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL

|Blood|2008|52